A groundbreaking global research initiative spearheaded by scientists from the University of Cambridge has uncovered a fascinating group of gut bacteria known as CAG-170, which appears to play a pivotal role in maintaining human health. This intriguing finding raises important questions about the intricate relationship between our gut microbiome and overall well-being.
CAG-170 represents a collection of gut bacteria that have only been identified through genetic analysis; notably, most of these bacteria cannot be cultivated in a laboratory setting. The research team utilized advanced computational techniques to detect the genetic markers of CAG-170 within gut microbiome samples collected from over 11,000 individuals spanning 39 countries.
The results were striking: individuals who were healthy exhibited significantly higher levels of CAG-170 compared to those suffering from various health issues, including inflammatory bowel disease, obesity, and chronic fatigue syndrome. This consistent pattern suggests that CAG-170 could serve as a valuable indicator of gut health in the future.
Notably, further examination of CAG-170 revealed its ability to generate substantial amounts of Vitamin B12, along with enzymes that facilitate the breakdown of diverse carbohydrates, sugars, and fibers present in our diets. Interestingly, researchers propose that the Vitamin B12 produced by CAG-170 may primarily benefit other bacterial species rather than directly aiding human hosts.
Dr. Alexandre Almeida, a prominent researcher in the Department of Veterinary Medicine at the University of Cambridge and the lead author of the study, emphasized the importance of CAG-170, remarking, "Our findings suggest that CAG-170 bacteria are integral components of the 'hidden microbiome,' crucial for human health by enhancing our digestion of essential food components and ensuring the smooth functioning of the entire microbiome."
Almeida elaborated, "By analyzing the gut microbiomes of thousands across 39 nations and examining 13 different diseases, we consistently observed that individuals with these health conditions had diminished levels of CAG-170 in their systems." The results of this comprehensive study have been published in the esteemed journal Cell Host & Microbe.
Unveiling the 'Hidden Microbiome'
This research builds upon Almeida's earlier work aimed at developing an extensive reference catalog of the genomes present within the human gut microbiome, known as the 'Unified Human Gastrointestinal Genome catalogue.' Through a method called metagenomics, the team was able to analyze the genomes of various microbes in one process, subsequently isolating the genetic material of individual species.
This approach led to the identification of over 4,600 distinct bacterial species, including more than 3,000 previously unrecognized varieties, highlighting the extensive and largely unexplored 'hidden microbiome.' This catalogue serves as a foundational resource, providing reference genomes for each species, including CAG-170, which researchers can now track in other microbiome samples.
Almeida noted, "Our earlier investigations revealed that nearly two-thirds of the species residing in our gut microbiome were entirely unknown until now. We lacked understanding of their functions, but our current research indicates that many of these species are fundamental yet underappreciated players in human health."
Three Key Lines of Evidence
The research team meticulously examined over 11,000 samples of gut bacteria sourced from individuals across 39 countries, focusing on both healthy subjects and those afflicted with 13 different diseases, such as Crohn’s, colorectal cancer, Parkinson’s disease, and multiple sclerosis. By comparing these samples against the Unified Human Gastrointestinal Genome catalogue, the researchers discovered that CAG-170 bacteria are the segment of the 'hidden microbiome' most strongly associated with positive health outcomes, a trend consistent across geographical boundaries.
In a secondary analysis, the team conducted a thorough computational evaluation of the gut microbiomes of more than 6,000 healthy individuals to identify which species played the most significant role in maintaining a balanced gut ecosystem. Once again, CAG-170 emerged as the group most consistently linked to health.
The third line of evidence involved assessing CAG-170 levels in individuals experiencing dysbiosis, a condition characterized by an imbalance in the gut microbiome. Lower concentrations of CAG-170 were correlated with a higher likelihood of gut imbalances, which are associated with numerous chronic conditions, including irritable bowel syndrome, rheumatoid arthritis, and mental health disorders like anxiety and depression.
Exploring Therapeutic Opportunities
Our gut microbiome consists of billions of bacteria representing approximately 4,600 different species. While each person's microbial composition is unique, their functions converge towards one goal: ensuring the body operates effectively.
Researchers aspire to deepen their understanding of a healthy gut microbiome's characteristics, allowing them to observe how it varies in individuals with specific health challenges and potentially devise strategies to correct imbalances through tailored probiotics. This recent study marks a significant stride toward realizing this vision.
Almeida remarked, "The probiotic industry has not kept pace with advancements in gut microbiome research; many people are still using probiotic strains that have been around for decades. We are only now discovering novel bacterial groups like CAG-170, which are crucial for our health, and targeted probiotics designed to support these groups could yield far greater health benefits."
Traditionally, investigations into the gut microbiome have concentrated on bacteria that can be cultured and studied in laboratory conditions. However, most CAG-170 bacteria do not fall within this category, necessitating innovative approaches to cultivate and examine them, paving the way for the development of new therapeutic options.
